[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-detail-343011-en":59,"doc-seo-343011-105":98},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":5,"data":60},{"doc_id":61,"user_id":62,"nickname":63,"user_avatar":64,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":66,"doc_content":67,"file_id":68,"file_url":69,"file_type":70,"file_size":71,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":72,"language_code":73,"site_id":74,"html_lang":73,"table_of_contents":75,"faqs":76,"seo_title":77,"seo_description":66,"update_tm":78,"read_time":79,"preview_page_count":19,"preview_urls":80},343011,8796095461564,"Liam","https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Study on the additional financial burden of breast cancer disease on cancer patients and their families - Financial toxicity in cancer","Breast cancer creates a measurable social and economic problem known as financial toxicity of cancer. This observational descriptive cross-sectional study examines extra expenses paid by patients and their families after diagnosis. Data were collected from November 2021 to March 2022 in Spain at the Medical Oncology Service, assessing additional costs, disability, daily living functioning, and caregiver burden. Results show substantial annual cancer-related costs and a significant reduction in average income after diagnosis.","TYPE Original Research PUBLISHED 03 July 2024  \nDOI 10.3389/fpubh.2024.1324334  \nOPEN ACCESS  \nEDITED BY  \nHai Fang,  \nPeking University, China  \nREVIEWED BY  \nDinesh Pendharkar,  \nSarvodaya Hospital and Research Centre, India  \nRinshu Dwivedi,  \nIndian Institute of Information Technology Tiruchirappalli, India  \n*CORRESPONDENCE  \nEduardo J. Fernandez-Rodriguez  \n [edujfr@usal.es](edujfr@usal.es)[ ](edujfr@usal.es)Alberto Garcia-Martin  \n [albergm@usal.es](albergm@usal.es)[ ](albergm@usal.es)RECEIVED 19 October 2023 ACCEPTED 19 June 2024 PUBLISHED 03 July 2024  \nCITATION  \nFernandez-Rodriguez EJ, Taboada-Taboada R, Garcia-Martin A, Sanchez-Gomez C,  \nSaez-Gutierrez S, Rihuete-Galve MI and Fonseca-Sánchez E (2024) Study on the additional financial burden of breast cancer disease on cancer patients and their families. Financial toxicity in cancer.  \nFront. Public Health 12:1324334 .  \ndoi: 10.3389/fpubh.2024.1324334  \nCOPYRIGHT  \n© 2024 Fernandez-Rodriguez, Taboada-Taboada, Garcia-Martin, Sanchez-Gomez, Saez-Gutierrez,  \nRihuete-Galve and Fonseca-Sánchez. This isan open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nStudy on the additional financial burden of breast cancer disease on cancer patients and their families. Financial toxicity in cancer  \nEduardo J. Fernandez-Rodriguez 1, 2*, Rocio Taboada-Taboada 1,  \nAlberto Garcia-Martin3*, Celia Sanchez-Gomez 2, 4, Susana Saez-Gutierrez 1, Maria I. Rihuete-Galve 1, 2, 5 and Emilio Fonseca-Sánchez 2, 5, 6  \n1 Deparment of Nursing and Physiotherapy, University of Salamanca, Salamanca, Spain, 2 Institute of Biomedical Research (IBSAL), Salamanca, Spain, 3 Deparment of Labour Law and Social Work, University of Salamanca, Salamanca, Spain, 4 Deparment of Evolutionary and Educational Psychology, University of Salamanca, Salamanca, Spain, 5 Deparment of Medicine, University of Salamanca, Salamanca, Spain, 6 Medical Oncology Unit, University Hospital of Salamanca, Salamanca, Spain  \nIntroduction: Breast cancer is among the most frequently diagnosed cancers worldwide, with 2.3 million new cases reported annually. The condition causes a social and economic impact known as financial toxicity of cancer. The study aims to explore the extra expenses borne by patients and their families on being diagnosed with breast cancer.  \nMethodology: An observational, descriptive, cross-sectional study was conducted. The data was collected between November 2021 and March 2022 at the Medical Oncology Service in Complejo Asistencial Universitario de Salamanca, Spain. The variables under investigation were additional economic costs, physical disability (as measured by the Barthel Index), instrumental activities of daily living (as measured by the Lawton-Brody Scale), and caregiver burden (measured using the ZARIT scale) .  \nResults: The final sample size was N = 107. The study yielded the following outcomes: the median age was 55 years old and the majority of participants were female, with a proportion of 99. 1% . The incidence rates for stage I and II were 31.8 and 35. 5%, respectively. The median Barthel score was 100 points, while the Lawton and Brody score were 8 points and the ECOG score was 2 points. The analysis of primary caregiver burden resulted in a median ZARITscore of 15 points. The expenses related solely to the cancer diagnosis totaled 1511.22 euros per year (316 .82 euros for pharmaceuticals; 487.85 euros for orthopedic equipment; 140.19 euros for home help; and 566.36 euros for housing adaptation or transfer to a hospital) . The average annual income before diagnosis was 19962.62 euros. However, after being dia","cbCainOyue3DreGr","https://ap.wps.com/l/cbCainOyue3DreGr","pdf",517544,"English","en",105,"# Introduction\n# Methodology\n# Results\n# Conclusion\n# Keywords","[{\"question\":\"What is the study’s primary goal regarding breast cancer?\",\"answer\":\"To explore the extra expenses borne by breast cancer patients and their families after diagnosis, framed as the financial toxicity of cancer.\"},{\"question\":\"How was the study conducted and when were data collected?\",\"answer\":\"It was an observational, descriptive, cross-sectional study. Data were collected between November 2021 and March 2022 at the Medical Oncology Service in Salamanca, Spain.\"},{\"question\":\"What financial outcomes were reported in the results?\",\"answer\":\"Cancer diagnosis-related expenses totaled 1511.22 euros per year, and average annual income decreased by 15.91% after diagnosis.\"}]","Study on the additional financial burden of breast cancer disease on cancer patients and their families - Financial toxicity in cancer | PDF",1790049393,25,[81,85,89,94],{"page_no":8,"url":82,"width":83,"height":84},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/eb7f591efd8276c8768ec09da48f3cf0.webp",983,1390,{"page_no":14,"url":86,"width":87,"height":88},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8708e29c7ff24ec2acf50d2ea0daadf4.webp",982,1388,{"page_no":90,"url":91,"width":92,"height":93},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1059b29a9b6b23c6f1a0d32ba7b09078.webp",981,1387,{"page_no":19,"url":95,"width":96,"height":97},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ddcbcab03d0acc34812abc12b6ad9e3.webp",980,1385,{"code":4,"msg":99,"data":100},"ok",{"site_id":74,"language":73,"slug":101,"title":65,"keywords":102,"description":66,"schema_data":103,"social_meta":156,"head_meta":158,"extra_data":160,"updated_unix":161},"study-on-the-additional-financial-burden-of-breast-cancer-disease-on-cancer-patients-and-their-families-financial-toxicity-in-cancer","",{"@graph":104,"@context":155},[105,118,138],{"@type":106,"itemListElement":107},"BreadcrumbList",[108,112,114,116],{"item":109,"name":110,"@type":111,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":113,"name":9,"@type":111,"position":14},"https://docshare.wps.com/document/",{"item":115,"name":40,"@type":111,"position":90},"https://docshare.wps.com/document/research-report/",{"item":117,"name":65,"@type":111,"position":19},"https://docshare.wps.com/document/study-on-the-additional-financial-burden-of-breast-cancer-disease-on-cancer-patients-and-their-families-financial-toxicity-in-cancer/343011/",{"url":117,"name":65,"@type":119,"image":120,"author":125,"headline":65,"publisher":127,"fileFormat":130,"inLanguage":73,"description":66,"dateModified":131,"datePublished":132,"encodingFormat":130,"isAccessibleForFree":133,"interactionStatistic":134},"DigitalDocument",{"url":121,"@type":122,"width":123,"height":124},"https://docshare.wps.com/thumbnails/study-on-the-additional-financial-burden-of-breast-cancer-disease-on-cancer-patients-and-their-families-financial-toxicity-in-cancer/343011.png","ImageObject",300,407,{"name":63,"@type":126},"Person",{"url":109,"name":128,"@type":129},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":135,"interactionType":136,"userInteractionCount":29},"InteractionCounter",{"@type":137},"ViewAction",{"@type":139,"mainEntity":140},"FAQPage",[141,147,151],{"name":142,"@type":143,"acceptedAnswer":144},"What is the study’s primary goal regarding breast cancer?","Question",{"text":145,"@type":146},"To explore the extra expenses borne by breast cancer patients and their families after diagnosis, framed as the financial toxicity of cancer.","Answer",{"name":148,"@type":143,"acceptedAnswer":149},"How was the study conducted and when were data collected?",{"text":150,"@type":146},"It was an observational, descriptive, cross-sectional study. Data were collected between November 2021 and March 2022 at the Medical Oncology Service in Salamanca, Spain.",{"name":152,"@type":143,"acceptedAnswer":153},"What financial outcomes were reported in the results?",{"text":154,"@type":146},"Cancer diagnosis-related expenses totaled 1511.22 euros per year, and average annual income decreased by 15.91% after diagnosis.","https://schema.org",{"og:url":117,"og:type":157,"og:title":65,"og:site_name":128,"og:description":66},"article",{"robots":159,"canonical":117},"index,follow",{"doc_id":61,"site_id":74},1790118734]